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Abstract (158 words) 
Cranial lymphatic vessels (LVs) are involved in transport of fluids, macromolecules and CNS 
immune responses. Little information about spinal LVs is available, because these delicate 
structures are embedded within vertebral tissues and difficult to visualize using traditional 
histology. Here we reveal an extended vertebral column LV network using three-dimensional 
imaging of decalcified iDISCO-clarified spine segments. Spinal LVs are metameric circuits exiting 
along spinal nerve roots and connecting to lymph nodes and the thoracic duct. They navigate in 
the epidural space and the dura mater around the spinal cord, and associate with leukocytes, 
peripheral dorsal root and sympathetic ganglia. Spinal LVs are VEGF-C-dependent and remodel 
extensively after spinal cord injury. They constitute an extension to cranial circuits for meningeal 
fluids, but also a route for perineural fluids and a link with peripheral immune and nervous circuits. 
Vertebral column LVs may be potential targets to improve the maintenance and repair of spinal 
tissues as well as gatekeepers of CNS immunity. 
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Introduction 
The lymphatic vasculature controls fluid homeostasis, macromolecular clearance and immune 
responses in peripheral tissues (Alitalo, 2011; Petrova and Koh, 2018). The brain was long 
considered to lack lymphatic vasculature, which has raised questions about how interstitial cerebral 
fluid (ISF) is cleared of waste products (Louveau et al., 2017; Abbott et al., 2018) and how immune 
surveillance of the brain is maintained (Ransohoff and Engelhardt, 2012; Engelhardt et al., 2016; 
Filiano, Gadani and Kipnis, 2017). ISF is formed by water and small solutes that are exchanged 
through the capillary walls between the blood vessels and the brain. It has a similar composition 
to the cerebrospinal fluid (CSF) which drains the brain ventricles and meninges and is mainly 
produced in the choroid plexus (Zappaterra and Lehtinen, 2012). The CSF has been described to 
dynamically exchange with ISF along glial “lymphatic” (glymphatic) non-vascular periarterial 
routes, without crossing the endothelial cell layer, and subsequently to be cleared from the brain 
into the subarachnoid space (Iliff, Goldman and Nedergaard, 2015; Engelhardt et al., 2016). The 
CSF outflow system involves specific extracranial lymphatic vasculature beds (Pollay, 2010; Proulx 
et al., 2017). In addition, cranial meningeal LVs (mLVs) have been recently identified and were 
suggested to drain CSF into deep cervical lymph nodes (dcLNs) (Aspelund et al., 2015; Louveau 
et al., 2015; Antila et al., 2017). In mice, cranial mLVs are mainly aligned alongside large dural 
venous sinuses, meningeal arteries and cranial nerves. Along the sagittal suture, the cranial 
lymphatic vasculature is rather discontinuous with valveless and small-diameter LVs, while it forms 
a larger network with valves toward the lateral and basal aspects of the skull (Aspelund et al., 2015; 
Louveau et al., 2015; Antila et al., 2017). Meningeal lymphatic vasculature also exists in the skull 
of primates, including common marmoset monkeys and humans (Absinta et al., 2017; Antila et al., 
2017). 
VEGF-C expression in vascular smooth muscle cells and VEGFR3 in lymphatic endothelial cells 
(LECs) are essential for the development of cranial mLVs (Antila et al., 2017; Blanchette and 
Daneman, 2017). The meningeal lymphatic vasculature develops later than the rest of the 
lymphatic network, first appearing at birth in the basal parts of the skull, then expanding during the 
neonatal period along dural blood vessels whose vascular smooth muscle cells supply the VEGF-
C (Antila et al., 2017). Classical immuno-histology on whole-mount preparations or cryo-sections 
showed that, during the first weeks after birth, LVs also developed a large network closely attached 
to the vertebral column (Antila et al., 2017). Vertebral LVs were observed in intervertebral spaces, 
ventrally and dorsally to the midline, as well as along spinal nerve roots, laterally and together with 
blood vessels. In the cervical spine, vertebral LVs appeared directly connected with cranial mLVs 
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located dorsally around the cisterna magna and ventrally around the foramen magnum. These 
observations suggested that cranial mLVs might extend caudally into the spinal lymphatic vascular 
system and connect from there to the peripheral lymphatic system. To test this model, we decided 
to produce a three-dimensional (3D)-map of the vertebral lymphatic system that respected 
structural interactions between the CNS and meninges, the surrounding bone and mesenchymal 
environment and the neighboring peripheral nervous system (PNS). This required us to preserve 
the overall bone structures around the CNS while simultaneously accessing and labeling the LVs 
of meninges contained within the protective layers of muscular and skeletal tissues.  
To do so, we used the iDISCO (immunolabeling-enabled three-dimensional imaging of solvent-
cleared organs) technique which enables volume imaging of immunolabeled structures in complex 
tissues, without disrupting tissue architecture (Renier et al., 2014, 2016). Imaging of iDISCO 
treated vertebral segments with a light sheet fluorescent microscope (LSFM) revealed an extensive 
lymphatic vasculature inside the vertebral canal. 
 
Results 
Lymphatic vasculature pattern in the thoracic spine 
To label vascular, immune and neural cell compartments within the intact vertebral column, we 
decalcified segments of 2-4 vertebrae dissected together with the surrounding muscle tissue along 
the rostro-caudal axis of the vertebral column. iDISCO tissue clearing and immunolabeling followed 
by light-sheet fluorescence microscope (LSFM) was used for 3D-reconstruction of the spinal LV 
network.  
Because we previously described LVs mainly in the cervical vertebrae (Antila et al., 2017), the 
iDISCO protocol was first applied to the thoracic spine, with the goal to characterize the three-
dimensional extension of LVs in the vertebral column (Fig. 1 A). Fig. 1 B illustrates a lateral view 
of Alizarin red staining of bones within a cleared spinal column segment to reveal the vertebrae, 
intervertebral spaces and ligamentum flavum. Fig. 1 C shows a schematic latero-frontal 
perspective view of a thoracic vertebral segment. Lymphatic endothelial cells (LECs) were labeled 
using polyclonal antibodies against two well-established LEC markers, the LYVE-1 cell surface 
receptor and the nuclear Prox-1 transcription factor (Wigle and Oliver, 1999; Jackson et al., 2001; 
Johnson et al., 2008). Prox-1 labeled LYVE-1 positive LECs and LYVE-1 negative cells within the 
spinal cord that were previously identified as oligodendroglial cells (Kaser-Eichberger et al., 2016) 
(Fig. S1, A and B). LYVE-1 labeled Prox1 positive LECs and Prox1-negative myeloid cells, as 
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previously reported (Kaser-Eichberger et al., 2016) (Fig. S1, A and B). LYVE-1 positive LECs 
within the vertebral column were negative for the blood vessel marker Podocalyxin (Testa et al., 
2009) (Fig. S1, C and H).  
Despite labeling of some non-LECs, both markers clearly revealed a dense lymphatic network that 
was present between vertebrae and appeared confined to the intervertebral spaces (Fig. 1, D and 
E and movies 1 and 2). A few longitudinal vessels linked adjacent intervertebral lymphatic circuits 
together along the spinal cord (Fig. 1, E and F). Each vertebral LV was also connected to the 
peripheral lymphatic system surrounding the vertebrae, dorsally through the ligamentum flavum, 
dorsolaterally along the dorsal facet joint and ventrolaterally through the intervertebral foramen 
along ventral nerve roots and dorsal root ganglia (DRGs) (Fig. 1, E and F). The overall vertebral 
lymphatic circuitry was surprisingly dense compared to the previously described lymphatic 
vasculature of skull meninges (Aspelund et al., 2015; Louveau et al., 2015; Absinta et al., 2017; 
Antila et al., 2017).  
We next used Imaris-3D image analysis software to illustrate the anatomy of meningeal lymphatic 
circuits within each vertebra and their relationship with the extra-vertebral LVs. Analyses were 
performed from global image acquisitions of the thoracic spine, such as the one on display in 
movie 2 which shows a succession of vertebral lymphatic units along the rostro-caudal axis. 
Images were then segmented to generate a color-coded map of LV circuits. In Fig. 1, G and H 
and movies 3 and 4 each color defines the Prox-1+ vascular pattern of one vertebra along three 
successive thoracic vertebrae (red, blue, green) as well as the peripheral lymphatic vasculature 
(white). This identifies a metameric organization of spine LVs. 
 
Vertebral unit lymphatic architecture  
We next mapped the LV network in the vertebral canal from the dorsal to the ventral part of a 
vertebra. Movie 2 and the corresponding view in Fig. 2, A and B show LVs around one segment 
of the thoracic spinal cord, and areas where higher magnification views were taken. Dorsally, 
semicircular lymphatic vessels navigate around the spinal cord, at the ventral border of the 
ligamentum flavum (Fig. 2 C). At the dorsal midline, these vessels contact lymphatic branches 
entering the epidural space from the overlying dense peripheral lymphatic vasculature in the 
intervertebral space between two spinous processes (Fig. 2 D). An inner and less complete LV 
circle lines the dura mater, hence two layers of LVs border the epidural space (Fig. 2 D). Laterally, 
at the level of the transverse facet joints, semicircular vessels including peripheral lymphatic 
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vessels from the dorsal plexus converge toward a lymphatic circle (blue arrow in Fig. 2 C). From 
this point, lymphatic vessels redistribute either radially via the periphery, or ventrally toward the 
emergence of the ventral spinal nerve root (red double arrow in Fig. 2 C). Movie 2 allows to follow 
the route of peripheral lymphatic vessels from their entry at dorsal midline to their lateral exit from 
the vertebral canal. At the intervertebral foramen, dorsal root ganglia (DRGs) are covered by LVs 
that converge from the ventral and dorso-lateral circuits at their proximal and distal end, 
respectively (arrowheads in Fig. 2 E). In addition to these two circuits, a few longitudinal connecting 
vessels link vertebral lymphatic units together (Fig. 2 F). Ventrally, a second circuit of semicircular 
lymphatic vessels converges toward the ventral spinal nerve root exit, while no lymphatic vessels 
are observed at the ventral midline (Fig. 2 G).  
We observed a similar LV pattern in other thoracic segments (n=5), allowing us to generate a 
schematic representation of these different compartments of the vertebral lymphatic circuitry with 
a specific color code for intervertebral circuits (red) and vertebral branches of the peripheral LV 
(blue) (Fig. 2 H).  
 
Epidural and dural vertebral lymphatic circuits are surrounded by myeloid cells  
To obtain 3D-resolution of LV localization in the spinal canal and meninges, Prox-1-labeled 
vertebral volumetric images were used to generate segmented images of membranes and the 
epidural space around the spinal cord. We enhanced the brightness of successive single image 
slices of Prox-1 labeled cervical and thoracic vertebrae to identify meninges, the epidural space 
and ligamentum flavum (Fig. 3A). We then manually delineated and colored the layers of 
meninges, dura mater or epidural space including the Prox1 label. Fig. 3 A shows one image slice 
with a color-code for meningeal layers (purple area) and the epidural space (green area). After 3D-
reconstruction of a stack of similarly processed image slices, we generated color-coded layer 
masks for the arachnoid and dura mater together (purple area in Fig. 3 B), or the dura mater and 
the epidural space together (green area in Fig. 3C). The overlay of both masks revealed that Prox-
1+ LVs mainly localized in the epidural space (green), while the underlying dura mater layer (white) 
includes ventral LVs around DRGs and a few LVs on each side of the ventral and dorsal midline 
(Fig. 3D and movie 5). As shown on a lateral view (Fig. 3E), dura mater LVs localized most 
extensively at bilateral DRGs. Interestingly, connecting vessels between two successive vertebrae 
(red arrows in Fig. 3E) navigate in the epidural space and appear to join LVs of the dura mater 
close to the DRGs (white arrows in Fig. 3E), suggesting a possible confluence of peripheral lymph 
and CSF at this level.  
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Vertebral LVs moreover appeared to be a privileged environment for immune myeloid cells, as was 
previously reported for skull lymphatics (Louveau et al., 2015). Pre-cleared segments of the 
vertebral column co-labeled with antibodies against LYVE-1 and the common leucocyte antigen 
CD45 show that CD45+ myeloid cells inside the vertebral canal are concentrated around LYVE-1+ 
vertebral LVs (Fig. 4, A-D).  
 
LV patterning varies between cervical, thoracic and lumbar spine 
We next examined the lymphatic vasculature at cervical and lumbar levels of the vertebral column. 
A first approach by confocal imaging of wholemount preparations of cervical and lumbar vertebrae 
showed differences in the pattern of cervical and lumbar LVs. More specifically, extra-vertebral 
LVs on the dorsal aspect of the spine were more abundant in lumbar compared to cervical 
vertebrae (Fig. S2, A-D). The variability of LV patterning along the vertebral column was analyzed 
in further detail by volume imaging.  
In the cervical region (Fig. 5 A), the dorsal extravertebral lymphatic plexus is reduced in size (green 
in Fig. 5 B) and intravertebral LVs exit ventrally and bilaterally through the intervertebral foramen 
to connect to cervical lymph nodes (Fig. S2, E and F). The short interspace between cervical 
vertebrae is associated with a lack of longitudinal intervertebral vessels and a direct lymphatic 
vessel connection from the ventral root to the lateral lymphatic circle of the neighboring vertebra. 
Thoracic vertebral LVs, as described above, are defined by a large dorsal extravertebral plexus 
(Fig. 5 C) and a direct connection from ventrolateral spinal roots to the thoracic lymphatic duct 
(Fig. 5 D). The thoracic and lumbar regions display similar extension and pattern of extravertebral 
and intravertebral LVs (Fig. 5, C and E). In lumbar vertebrae, the ventro-lateral circuits that exit on 
each side of the vertebral canal connect to lymph nodes. As shown in green in Fig. 5 F, lymphatic 
vessels circumvent the ventral body of the lumbar vertebra, converge on the ventral midline and 
split into two branches running toward the pair of aortic lumbar lymph nodes. Therefore, the 
vertebral LV architecture is conserved along the vertebral column, but the extension of 
extravertebral and intravertebral vessels around the spinal cord and their connection to the 
peripheral lymphatic system differs between the cervical, thoracic and lumbar vertebral levels. 
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Vertebral lymphatic vasculature contacts the sympathetic nervous system  
We found that LVs covering the DRG dura mater (Fig. 2F) extend a collateral branch, bilaterally 
along the spine, that contacts paravertebral Prox1low ganglia (Fig. 6, A and B). Prox1 is known to 
be expressed in the sympathetic neuronal lineage (Holzmann, Hennchen and Rohrer, 2015) and 
double-labeling with antibodies against Prox-1 and Tyrosine Hydroxylase (TH), a specific marker 
of adrenergic nerves and ganglia, confirmed that specific branches emerging from vertebral LVs 
connect to TH+/Prox1low sympathetic ganglia (Fig. 6 C) and that lymphatic vessels double stained 
with Prox-1 and LYVE-1 contact one sympathetic ganglion per spinal level (Fig. 6 D-F). 
Complementary analyses by high resolution confocal imaging on vertebral column cryosections 
indicated that the close spatial relationship between LV and sympathetic ganglia (Fig. 6 G, H) 
remained at the surface of the ganglion cortical layer (Fig. 6I). These data reveal a hitherto 
unknown anatomical interaction between the autonomous nervous system and lymphatic vessels 
derived from spinal meningeal LVs. 
 
Vertebral LVs respond to VEGF-C and spinal cord injury 
We next tested if vertebral LVs responded to the major lymphangiogenic growth factor VEGF-C. 
Adult mice (2months of age) were injected with AAV-VEGF-C or -empty control (n=4) into the 
cisterna magna, followed by analysis one month later (Fig. 7 A). Fig. 7 B-E and movie 8 show 
Prox-1 staining of cervical vertebrae. Compared to control injected mice (Fig. 7, B and D), VEGF-
C injected mice showed a strongly expanded LV network, in particular of dorsolateral lymphatic 
rings in the intervertebral disk (Fig. 7, C and E and movie 6).  
The capacity of adult vertebral LVs to grow in response to growth factors suggested that this 
circuitry may respond to pathological conditions affecting the spinal cord and more broadly the 
CNS. Based on the prediction that a spinal cord trauma generates tissue destruction, accumulation 
of cell debris, and thus requires from the LV a supplement of tissue clearance and immune survey, 
we applied a direct injury at the thoraco-lumbar level, using a needle to inject sodium chloride (2µl) 
into the spinal cord (Fig. 7F). Within a week after the surgery, a robust lymphangiogenesis was 
observed in extravertebral and intravertebral lymphatic vasculature in the injured mice (Fig. 7, G-
N and movie 7).  
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Discussion  
We here used the i-DISCO protocol combined with LSFM to generate a map of thoracic vertebral 
column LVs (Fig. 8). We reveal an extensive and complex lymphatic vasculature in the spinal 
column, surprisingly dense in comparison to the one that covers the cranial dura mater. Previous 
literature has reported the presence of LVs on whole mount preparations of vertebral dura mater 
in monkeys (Miura, Kato and von Lüdinghausen, 1998) and on sections of intact and injured 
vertebral tissue in humans (Kashima, Dongre and Athanasou, 2011). These studies identified 
elements of lymphatic vasculature in the spine, such as the dura mater and epidural lymphatic 
circuits and the absence of LVs in vertebral bones and intervertebral disks in the intact spine. We 
here extend these findings by 3D-views of lymphatic vasculature organization and reveal 
interactions with surrounding tissues along the spine (Fig. 8).  
Each vertebra is drained by semicircular dorsal and ventral vessels, which exit the vertebral column 
at intervertebral foramen. Vertebral LVs extend along spinal nerve roots to reach either lymph 
nodes in the cervical and lumbar regions, or the thoracic lymphatic duct in the thoracic region. The 
vertebral lymphatic network is thus organized as a metameric network of peripheral LV-connected 
vertebral lymphatic units that are interconnected by a few thin longitudinal vessels. The absence 
of large longitudinal dorsal or ventral LVs suggests that the main flow of vertebral lymph is not 
descending as a continuous stream from the cisterna magna along the vertebral column axis, but 
is rather drained at the level of each vertebra. In addition to dura mater lymphatic circuits, the 
vertebral lymphatic vasculature includes an extensive network of epidural vessels that are located 
in the intervertebral tissue and beneath the ligamentum flavum and .appear to drain the non-CNS 
peripheral lymph of the vertebral column. 
Pioneer studies in the late 19th and early 20th centuries (Schwalbe, 1869); (Quincke H, 1872); (Orr 
and Rows, 1907) and later works of Ivanow (Ivanow, G., 1927) and Brierley and Fields (Brierley 
and Field, 1948) had investigated the flow of the lymph stream along the spine and in the spinal 
roots of the cord as well as lymphatic pathologies and infectious agent propagation in the spine, 
providing ‘a body of evidence that lymphatics play a part probably not subordinate to that of the 
blood vessels as channels by which infectious agents (toxins, polyomyelitis, tetanus) are conveyed 
to the cord and distributed within it (Bruce and Dawson, 1911). These predictions find support in 
the present imaging of extended vertebral lymphatic circuits that contact both peripheral lymph and 
CSF. 
 It is striking to note that there is a regional variation in the LV size, which is inversely correlated to 
the volume of CSF, with large cerebral ventricular volumes associated with a discrete network of 
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cranial mLVs and a small vertebral ependymal volume correlated with a large vertebral lymphatic 
vasculature. One possible explanation is that vertebral LVs strongly contribute to the reuptake of 
the CSF that is continuously produced by the ventricular choroid plexus and circulates top-to-
bottom along the spinal cord. This model is supported by presence of dura mater LVs in the spine 
and their dense location around spinal nerve root exits. A corollary of this hypothesis is that 
glymphatic drainage of interstitial fluids may be faster in the spinal cord than in the brain. A second 
and likely possibility is that the largest part of vertebral LV drains peripheral lymph, as suggested 
by the large network of epidural vessels that extends into the vertebral canal from the peripheral 
lymphatic system.   
Vertebral LVs localize mainly at the level of intervertebral ligaments or joints, much like cranial 
lymphatics that navigate in skull commissures alongside blood vasculature and spinal nerves 
(Antila et al., 2017). They also circulate through the fat tissue filling the epidural space intercalated 
between the dural mater and intervertebral ligaments. We and others find that vertebral lymphatic 
vessels avoid bone tissues (Edwards et al., 2008). Interestingly, the presence of LVs inside bone 
is observed in patients with vanishing bone disease (also called Gorham Stout disease GSD) 
(Hominick et al., 2018). GSD is a sporadic disease characterized by the presence of lymphatic 
vessels in bone and progressive bone loss. In severe cases, the disease progresses until entire 
bones are lost and replaced by fibrous tissue. GSD can affect any bone in the body, but it most 
frequently affects the ribs and vertebrae, with poor prognosis (Lala et al., 2013; Dellinger, Garg 
and Olsen, 2014). In mice, transgenic VEGF-C overexpression in bone under the control of the 
Osx promoter induces lymphatic invasion into bone and osteoclast-mediated bone loss, mimicking 
essential aspects of GSD (Hominick et al., 2018). Mechanisms preventing LV formation in bone 
are currently unknown. 
 
In contrast to skull commissures between skull cap bones, which are few, narrow and fixed, the 
vertebral disks, joints and ligaments between vertebral bones are numerous, large and mobile. 
They sustain the integrity and flexibility of the spine, which is predicted to require extensive 
interstitial fluid drainage. The large network of vertebral epidural LV appears to be exquisitely 
adapted to this extensive drainage of non-neural peripheral tissues in the spine and to provide 
each vertebra with its proper clearance system. It is predictable that defective spine LVs will alter 
vertebral and intervertebral tissue maintenance, leading to spine orthopedic pathologies. 
The spine LV circuitry includes epidural vessels in the peripheral lymphatic system that likely drain 
intervertebral non-neural tissues, especially the epidural fat tissue of the spinal cord, and dura 
mater vessels that may drain CNS tissue fluids at possible hot-spots close and around the DRGs 
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as well as at more restricted positions on each side of the dorsal and ventral midline. These two 
circuits appear to be linked, since a part of  especially LVs connecting vertebrae together, circulate 
through the epidural space before entering the dura mater around the DRGs and exiting the spinal 
canal. It remains to be determined whether both circuits converge to the same or different lymph 
nodes or lymphatic ducts.  
The proximity of two distinct epidural and dura mater LV circuits in the spine raises questions about 
the protection of the privileged immune status of the CNS. Like in skull (Louveau et al., 2015), a 
specific interaction between LVs and CD45 leucocytes is observed along the spine (Fig. 3). The 
spinal cord lymphatic vasculature thus appears as a potentially important immune surveillance 
interface between the CNS and peripheral tissues. The cervical and lumbar regions directly drain 
into cervical and lumbar lymph nodes, respectively, which suggests that the peri-lymphatic 
dendritic immune cells may rapidly transfer to lymph nodes and initiate lymphocyte activation 
against specific pathogens or antigens. On the other hand, the promiscuity of epidural and dura 
mater LV in the spine may predispose to the propagation of peripheral infections through the 
vertebral canal toward neural tissues, especially peripheral nervous ganglia which are in close 
contact with the spine LV (Fig. 6). For example, epidural LVs may provide entry for meningitis 
infection into spinal meninges. The contact zone between DRGs and LVs connected to the thoracic 
duct and lymph nodes appears as another potential gate for entry into the CNS for pathogens 
drained by the peripheral lymph. This possibility is in agreeement with the early detection of bovine 
scrapie protein in the mesenteric lymph nodes and DRGs of lemurs or cattles infected orally with 
the agent of bovine spongiform encephalopathy (BSE) (Bons et al., 1999; Franz et al., 2012).  
The spine elicits a variety of diseases including infections caused by either a bacterial or a fungal 
infection transfered into the spine through the bloodstream (Darouiche, 2006), acute spinal cord 
compressions resulting from trauma, cancer, epidural abscess, or epidural hematoma (Ropper and 
Ropper, 2017), and degenerative spine disorders, a common condition especially in the ageing 
Western population (Brinjikji et al., 2015). Vertebral LVs are a potential target for these pathologies, 
as they are pipes to propagate infections and to drain excessive interstitial fluids. The vertebral 
column is also the commonest site for skeletal metastastic tumors, with breast, prostate and lung 
cancers being the most common primary sources; as many as 70% of cancer patients have spinal 
metastases, and up to 10% of cancer patients develop metastatic cord compression (Choi et al., 
2010). Since lymphatics may serve as conduits for primary tumor cells in metastatic spreading 
(Karaman and Detmar, 2014), specific interference in the vertebral lymphatic vasculature could 
reduce or prevent the spinal metastasis process. Alternatively, lymphatic vessels are the first 
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barrier for antigen-presenting cells that are transported into the next lymph node to initiate an 
adaptive immune response (Card, Yu and Swartz, 2014). Facilitating the entry of immune cells into 
vertebral lymphatic vessels could thus also potentially improve the efficiency of immune checkpoint 
inhibitor treatments to trigger the adaptive immune response against spinal tumor cells.  
We find that adult vertebral LVs rapidly expand in response to VEGF-C or tissue injury. Tissue 
injury causes inflammatory processes and calls for repair mechanisms. These processes require 
increased LV activity and thus lymphangiogenesis which is likely VEGF-C/VEGFR3 signaling 
dependent, as in chronic skin inflammation (Hagura et al., 2014) and macrophage VEGF-C-driven 
(Ji, 2012). Spine LVs and VEGF-C may thus be new therapeutic targets to support and improve 
these attemps to protect and repair injured spine tissues.  
Vertebral LVs never contact the spinal cord tissue, even upon VEGF-C overexpression or acute 
spine lesion. Like cranial LVs, vertebral LVs are thus unlikely to reuptake CSF circulating through 
perivascular spaces of the spinal cord and pia mater. In contrast, vertebral LVs are closely apposed 
around the somatic and autonomous nervous ganglia chains. The targeting of paravertebral 
sympathetic chains by specific vertebral LVs is another discovery resulting from the spine volume 
imaging. Although no lymphatic vascularization of sympathetic ganglia was observed, lymphatic 
vessels may provide molecular signals to the sympathetic neurons that control vascular tone of 
lymphatic ducts and cerebral arteries and arterioles. Previous observations also showed that 
adrenergic fibers connect to the thoracic lymphatic duct and also innervate the wall of lymph node 
arterioles (Villaro, Sesma and Vazquez, 1987; Mignini et al., 2012). The crosstalk between spine 
LV and the sympathetic system is thus likely relevant for the regulation of peripheral lymph and 
glymphatic drainage and may coordinate them with the activity of brain and spine tissues. We 
speculate that a regulatory loop may link meningeal LV, sympathetic chain neurons and both CNS 
and peripheral fluid drainage.  
To conclude, this study shows that the volume imaging technique allows the description of 
neurovascular systems by preserving the anatomy and the 3D-continuity of vascular and neural 
structures. In particular, we have revealed a new set of information on the anatomical organization 
and plasticity of the lymphatic vasculature along the spine. Our findings identify vertebral LVs as a 
potential targets for improving the maintenance and repair of vertebral tissues as well as a 
gatekeeper of CNS immunity.   
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Figure legends 
Fig 1. Segmental pattern of the vertebral lymphatic vasculature in the thoracic spine 
(A) Alcian blue/Alizarin red staining of the mouse vertebral column with boxes indicating position 
of images shown in Figs 1-4 (thoracic vertebrae) and 5 (cervical and lumbar vertebrae), spatial 
orientation (A: anterior, D: dorsal, L: lateral, V: ventral). (B, C) Alizarin red staining of a thoracic 
vertebral column segment (B) and corresponding latero-frontal perspective schematic view (C). 
Two successive vertebrae are delimited by red/blue dots. DM: dura mater, LF: ligamentum flavum, 
LM: leptomeninges (pia mater and arachnoid), SC: spinal cord, SN: spinal nerve, blue arrow: 
dorso-lateral facet joint, red arrowhead: ventral intervertebral disk, blue star: intervertebral 
foramen, red (B) or black (C) star: ventral vertebral body. (D) Dorsal view of LYVE-1 staining. Red 
and blue areas correspond to two successive vertebrae. Note LVs lining ligamentum flavum. (E, 
F) Dorsal (E) and lateral (F) views of the Prox-1 expression pattern. Red and blue areas correspond 
to two successive vertebrae. Salmon arrows: intervertebral LVs, red arrow: dorsal LVs, red star: 
vertebral ventral body. (G, H) Segmented images of the Prox-1 LV network (fronto-dorsal (G) and 
lateral (H) views) highlighting three successive vertebral LV units (red, blue, green).  
 
Fig 2. Organization of individual thoracic vertebral column lymphatic units 
 (A) Frontal view of a cleared thoracic vertebra stained with an anti-Prox-1 antibody. Red star: 
vertebral ventral body, SC: spinal cord. (B) Magnification of red boxes referring to images in C-G. 
(C) Semicircular dorsal LVs (red arrow) surround the spinal cord, exit dorso-laterally (blue arrow) 
and also extend a latero-ventral connection (double red arrows) to the ventral nerve root (see 
double arrow in F). Note Prox1 positive cells in SC and perivertebral muscles (M), FJ: facet joint.  
(D) At the ventral face of the ligamentum flavum (LF) located between two spinous processes, 
dorsal LVs (blue arrows) enter the vertebral canal and join semicircular LVs (red arrows). Note 
circles of LVs bordering the upper side of the epidural space (ES). (E) Ventro-lateral LV circuitry 
around DRG (red arrowhead). Blue dotted-lines: spinal nerve roots, red dotted-lines: DRG. (F) 
Lateral view with intervertebral LVs (salmon arrows), red dotted-lines: DRG. (G) Two ventral 
branches arising on each side of the ventral midline (VM) and reaching the DRG (see single red 
arrows in F). (H). Schematic representation of a frontal view of a thoracic vertebral LV unit. 
Longitudinal connecting vessels between vertebral units are not represented. FJ: facet joint; LF: 
ligamentum flavum; ES: epidural space; DRG: dorsal root ganglia; VM: ventral midline; SC: spinal 
cord. Black letters referring to images in C-G. 
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Fig 3. Epidural and dural lymphatic circuits of the spine 
(A) 2D-single frontal image slice (2µm thick) of the cervical vertebral column with enhanced 
brightness to reveal Prox-1-expressing nuclei and spinal tissues including spinal cord (SC), 
meninges including pia mater (P), arachnoid (A) and dura mater (D), the epidural space (ES) and 
the ligamentum flavum (LF). A color-coded segmentation of layers around the spinal cord shows 
the meninges in purple and the dura mater plus the epidural space in green. (B-D) 3D-
reconstruction of frontal images of the cervical vertebral column with color-coded layers: the 
arachnoid and dura mater in purple (B); the dura mater and epidural space in green (C); combined 
layer marks showing the arachnoid in purple, the dura mater in white and the epidural space in 
green (D). A noticeable LV network fills the epidural space (green) while dura mater LVs (white) 
are mainly restricted to DRGs (white arrows) and few branches on each side of the dorsal and 
ventral midline. (E) 3D-reconstruction of lateral images of the thoracic vertebral column with color-
coded layers illustrated in (D). Blue dotted-lines: bilateral DRGs; salmon arrows: intervertebral LVs; 
Red star: vertebral ventral body. 
 
Fig 4. Interactions of spinal LVs with immune cells 
Double labeling of cleared thoracic vertebral column segments with LYVE-1 (purple in A, C, D) and 
CD45 (green in A, B, D) to identify myeloid cells. (B-D) are magnifications of white box in (A). 
Merged pictures (D). Note that myeloid cells concentrate along LVs. White star: vertebral ventral 
body; SC: Spinal cord.  
 
Fig 5. Variations of LV patterns along the vertebral column 
Pattern of Prox-1+ LVs in the cervical (A, B), thoracic (C, D) and lumbar (E, F) vertebral column. 
Left panels show frontal views, right panels show connection to peripheral lymph nodes (LN) and 
thoracic duct (TD). (A, C, E). Note fewer LVs in the dorsal plexus between intervertebral spinous 
processes of cervical and lumbar vertebrae compared to thoracic ones (blue arrows). Also note 
differences in ventral root exit circuits between regions (salmon arrows, A ,C, E). (B, D, F). LV 
ventral exit circuits (green) and deep cervical LNs (B), thoracic duct (D) or connections to aortic 
lumbar LNs (F). Red star: vertebral ventral body; SC: spinal cord; Ao: Aorta. 
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Fig 6.  Lymphatic vessel connections with sympathetic ganglia 
(A, B). Thoracic Prox-1+ LVs contact paravertebral sympathetic ganglia (SG) (blue arrow),. White 
dotted-lines: DRG. (C) Prox-1 (white) and tyrosine hydroxylase (TH, red) double labeling shows a 
ventral LV branch contacting a paravertebral TH+ sympathetic ganglion (blue arrow). (D-F). Prox-
1 (white) / LYVE-1 (red) double-labeling of the LV-SG connection (blue arrow). (G-I). 2D-confocal 
images of cervical cryosections labeled with LYVE-1 (white), TH (red), and Dapi (Blue). White box: 
area magnified in (H) and (I). A LV contacts a TH+ SG (blue arrow). Note a second ventral LV 
branch running along the SG, without entering its cortical layer (G-I, salmon arrow). This branch is 
also seen in panel (B) (salmon arrow). White dotted-lines: DRG; Red star: vertebral ventral body; 
SC: spinal cord. 
 
Fig 7. Spinal LVs expand in response to VEGF-C and injury 
(A-E). Response of vertebral LVs to AAV-control or AAV-VEGF-C delivery into the CSF. (A) 2-mo 
mice received Intra-cisterna magna injection of AAVs and were analyzed by 3D-iDISCO one month 
later. Frontal views (B, C) and lateral views (D, E) show that AAV-VEGF-C (C, E) induced 
lymphangiogenesis in the cervical vertebral column as compared to AAV-control (B, D). Red star: 
vertebral ventral body; SC: Spinal cord. 
(F-J) Spinal cord (Sc) lesion. (F) Experimental procedure: 2ul NaCl were injected into the spinal 
cord at the indicated level and mice were analyzed one week later. Frontal views (G, H) and lateral 
views (I, J) of Prox-1+ LVs. Note that SC lesion induces robust lymphangiogenesis but LVs do not 
enter lesioned SC tissue. Red star: vertebral ventral body; SC: Spinal cord. 
 
Fig 8. Schema of thoracic vertebral column LVs 
LVs around spinal cord (gray), in the epidura space (green), in the dura mater (purple), extra-
vertebral LV ventral connexion with SG and TD  (blue). Blue dots indicate connexion with extra-
vertebral lymphatic networks. Black star: vertebral ventral body; DRG: dorsal root ganglia, FJ: facet 
joint, LF: ligamentum flavum, SC: Spinal cord; SG: sympathetic ganglia.  
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Supplementary data: 
 
Fig. S 1: LVs and blood vasculature in the thoracic vertebral column 
(A, B) Prox-1 (white) / LYVE-1 (red) double staining of a clarified thoracic vertebral column 
segment. Note overlap of Prox-1 and LYVE-1 labeling in LVs (arrowheads). Also note Prox-1-
labeling of SC oligodendrocytes (A) and LYVE-1 staining of myeloid cells in meninges (arrows, B). 
(C-H) Double labeling of a clarified thoracic vertebral column segment with LYVE-1 (green) and 
Podocalyxin (purple) to identify blood vessels. F-H: magnifications of boxed areas in C-E. White 
star: vertebral ventral body; SC: Spinal cord. 
 
Fig. S 2 : LV patterning varies between cervical, thoracic and lumbar spine 
(A-D) Whole-mount immunostaining of Prox1-eGFP reporter mice showing lymphatic vasculature 
(green, gray). (A) Dorsal lymphatic vasculature around cisterna magna and vertebrae in cervical 
and thoracal regions. (B) Close-up of lymphatic vessels around cisterna magna in close 
association with the LVs around first cervical vertebra. (C) Side-view of the vertebral LVs 
connecting longitudinally with each other (marked with blue asterisks) and surrounding the spinal 
nerves (SN). (D) Close-up of vertebral lymphatic vessels in the dorsal aspect of the spine showing 
their localization mainly in intervertebral spaces. Blue arrowheads mark lymphatic valves. Data 
shown are representative n=3-6 per one staining. Scale bars: 1 mm (A), 200 µm (B, C), 400 µm 
(D). 
(E, F) Prox-1-staining of a cervical vertebral segment shows connection between a LV surrounding 
the DRG and a dcLN (blue arrows). (F): higher magnification view of boxed area in (E).  Red star: 
vertebral ventral body; SC: Spinal cord. 
 
Movie 1: Lymphatic vasculature of a thoracic vertebral segment labeled with LYVE-1 
antibody 
 
Movie 2: Lymphatic vasculature of a thoracic vertebral segment labeled with Prox-1 
antibody 
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Movie 3: Time-lapse z series of the Prox-1-labeled lymphatic vasculature of a thoracic 
vertebral segment  
 
Movie 4: 3D-image segmentation of Prox-1-labeled LVs of a thoracic vertebral segment  
 
Movie 5: 3D-image segmentation of Prox-1-labeled LVs in meningeal and epidural layers 
around the cervical spinal cord. 
Movie 6: Prox-1-labeled cervical LVs following AAV-VEGF-C administration 
 
Movie 7: Prox-1-labeled lumbar LVs at one week after spinal cord injury 
 
Materials and methods 
 
Study approval 
All mouse experiments were approved by the Institutional Animal Care and Use Committee of ICM 
Brain and Spine Institute and Yale University.  
 
Mice  
C57BL/6 background mice were used for all the experiments. Littermate mice were used as 
controls. Mice were considered as adults at 2 to 3-months (mo) of age.  
 
Tissue preparation 
Mice were given a lethal dose of Sodium Pentobarbital (Euthasol Vet) and perfusion-fixed through 
the left ventricle with 10ml ice-cold PBS then 20ml 4% paraformaldehyde (PFA) in PBS after 
puncture of the right atrium. To dissect the spine, the skin was completely removed, all the organs 
were eliminated and the ribs were completely cut to keep the vertebra from the cervical part until 
the lumbar part with the whole spinal cord inside. All the surrounding tissue as muscles, aorta, 
ligaments were maintained around vertebral column. The spine was cut into pieces of about 0,5cm 
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(1 to 3 vertebrae) corresponding to the cervical, thoracic and lumbar regions. The different spinal 
segments were immediately immersed in ice-cold 4% PFA, fixed overnight at +4°C, washed in 
PBS, and processed for staining. 
 
Samples pretreatment in methanol for iDISCO protocol 
We used the classical iDISCO protocol ((Renier et al., 2014) http://www.idisco.info). In detail, fixed 
samples were dehydrated progressively in methanol/PBS, 20%, 40%, 60%, 80% and 100% for 1 
hr each (all steps were done with agitation). They were then incubated overnight in a solution of 
Methanol 33%/dichloromethane 66% (DCM) (Sigma 270997-12X100ML). After 2 x 1h washes with 
methanol 100%, samples were then bleached with 5% H2O2 in methanol (1 vol 30% H2O2/ 5 vol 
methanol) at 4°C overnight. After bleaching, samples were rehydrated in methanol for 1 hr each, 
80%, 60%, 40%, 20% and PBS. To clarify vertebral bone, we here added a decalcification step 
using Morse solution (1/1 tri-sodium citrate and 45% formic acid) during 30min at RT. Samples 
were then washed rapidly with PBS then incubated 2x 1h in PTx2 (PBS/0.2% Triton X-100). At this 
step they were processed for immunostaining. 
 
Immunolabelling iDISCO protocol 
Pretreated samples were incubated in PBS/0.2% Triton X-100/20% DMSO/0.3M glycine at 37°C 
for 24h, then blocked in PBS/0.2% Triton X-100/10% DMSO/6% Donkey Serum at 37°C for 24h. 
Samples were incubated in primary antibody dilutions in PTwH (PBS/0.2% Tween-20 with 10mg/ml 
heparin) /5% DMSO/3% Donkey Serum at 37°C for 6 days. Samples were washed five times in 
PTwH until next day, and then incubated in secondary antibody dilutions in PTwH/3% Donkey 
Serum at 37°C for 4 days. Samples were finally washed in PTwH five times until the next day 
before clearing and imaging. 
 
iDISCO tissue Clearing 
Immunolabeled samples were dehydrated progressively in methanol in PBS, 20%, 40%, 60%, 80% 
and 100% each for 1 hr. They were then incubated overnight in a solution of Methanol 33%/DCM 
66% followed by incubation in 100% DCM for 2x 15 minutes to wash the methanol. Finally, samples 
were incubated in DiBenzyl Ether (DBE) (without shaking) until cleared (4 hr) and then stored in 
DBE at room temperature before imaging. 
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Cryostat immunostaining 
For cryosections of the spinal canal, the fixed tissues underwent decalcification with 0.5 M EDTA, 
pH 7.4, at 4°C. When the bone was soft, samples were washed thoroughly with PBS and immersed 
in PBS containing 20% sucrose and 2% polyvinylpyrrolidone for 24 h at 4°C, embedded in OCT 
compound (Tissue-Tek), and frozen for storage at −80°C. 50–100-μm-thick sections were cut using 
a cryostat (Microm HM 550/CryoStar NX70; Thermo Fisher Scientific), air-dried, encircled with a 
pap pen, permeabilized with 0.3% PBS-TX, washed with PBS, and blocked in 5% donkey serum 
in PBS-TX at RT. After overnight primary antibody incubation at 4°C in the same solution, the 
sections were washed with PBS and incubated with the appropriate fluorophore-conjugated 
secondary antibodies diluted in 0.3% PBS-TX for 1–2 h at RT. After washes with PBS, the sections 
were mounted with Vectashield mounting medium (Vector Laboratories), sealed with Cytoseal 60, 
and imaged as soon as possible. 
 
Antibodies  
The following primary antibodies were used for iDISCO protocol of mouse tissues: Rat anti–mouse 
podocalyxin (1:2500 MAB1556; R&D Systems), goat anti–human PROX1 (1:1200, AF2727; R&D 
Systems), rabbit anti–mouse LYVE-1 (1:800;11-034, AngioBio), goat anti-mouse CD45 (1:2000, 
AF114; R&D Systems), rabbit anti–mouse Tyrosine Hydroxylase (1:1500, T9237-13, United States 
Biological). 
The primary antibodies were detected with the corresponding Alexa Fluor -555, -568 or -647 
conjugated secondary antibodies from Jackson ImmunoResearch at 1/1000 dilution in all different 
conditions. 
 
Light-Sheet and Confocal Imaging 
Cleared samples were imaged in transverse orientation with a light-sheet microscope 
(Ultramicroscope II, LaVision Biotec) equipped with a sCMOS camera (Andor Neo) and a 23/0.5 
objective lens (MVPLAPO 23) equipped with a 6 mm working distance dipping cap. Version v144 
of the Imspector Microscope controller software was used. The microscope chamber was filled 
with DBE.  We used one laser configuration. The light sheet was generated by scanning a 
supercontinuum white light laser, filtered with the following excitation band pass filters: 560/30nm 
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(Alexa Fluor -568 or- 555) or -617/83nm (Alexa Fluor-647). In this configuration we matched the 
xy width of the light sheet to the sample and NA. Samples were generally imaged under 45% laser 
power. We used the following emission filters: 595/40 for Alexa Fluor-568 or -555, and -680/30 for 
Alexa Fluor-647. Stacks were acquired using 2μm z steps and a 30ms exposure time per step. 
Pixel sizes ranged from 5.16 to 0.52 µm, with the zoom factor used for acquisition (8X). Mosaic 
acquisitions were done with different number of frame (X, Y) 2x2; 3x2 or 3x3 in function of the 
samples size. 
Laser scanning confocal micrographs of the fluorescently labeled brain were acquired using a 
Leica TCS SP8 confocal microscope (air objectives 10× Plan-Apochromat with NA 0.45 and 25× 
Plan-Apochromat with NA 1.1) with multichannel scanning in-frame. 
 
Image Processing and Analysis 
For display purposes in the figures, a gamma correction of 1.47 was applied on the raw data 
obtained from the light-sheet microscope.  
Images acquired with Imspector acquisition software in tif fomat was converted with Imaris File 
Converter to have IMS files. Mosaics were reconstructed with Imaris stitcher then Imaris software 
(Bitplane, http://www.bitplane.com/imaris/imaris) was used to: generate the orthogonal projections 
of data shown in all figures;  perform area segmentation on a stack of image slices and apply a 
color code to selected lymphatic networks. 
 
AAV injection 
Intra cisterna magna (CM) injection was done into adult male C57BL/6J mice of 8–10 wk of age. 
A single dose of 2 μl (109 viral particles per μl) of AAV encoding VEGF-C (Anisimov et al., 2009). 
Mice were anesthetized with isoflurane (induction 4%, maintenance 2%) and placed in a 
stereotactic apparatus (Stoelting). Injection into the CM was done using a Hamilton syringe with a 
34-G needle and a flow rate of 0.5 μl/min. The needle tip was retracted 2 min after the injection. 
100µl of 0.05 mg/kg of Buprecar solution (administered subcutaneously) was used to relieve 
postoperative pain. The AAVs of serotype 9 were produced by the AAV Gene Transfer and Cell 
Therapy Core Facility, HiLIFE, University of Helsinki (He et al., 2005; Bry et al., 2010; Calvo et al., 
2011). 
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Spinal cord lesion 
Adult male C57BL/6J mice of 8–10 wk of age were used. Lesions were induced in the spinal cord 
by a stereotaxic injection of sterile 0.9% NaCl solution. Prior to the surgery, mice were anesthetized 
by intraperitoneal injection of ketamine (90mg/kg) and xylazine (20mg/kg) cocktail. Two 
longitudinal incisions into longissimus dorsi at each side of the vertebral column were performed, 
and the muscle tissue covering the column was moved to the side. Animals were placed in a 
stereotaxic frame, the 13th thoracic vertebra was fixed in between the bars designed for 
manipulations on mouse spinal cord (Stoelting,Wood Dale, IL), and intravertebral space was 
exposed by removing the connective tissue. An incision into dura mater was performed using a 
30-gauge needle, and NaCl was injected using a glass micropipette attached via a connector to a 
Hamilton’s syringe and mounted on a stereotaxic micromanipulator. Following injection, the muscle 
sheaths were sutured with 3/0 Monocryl, and the skin incision was closed with 4/0 silk. After 7 days 
post injection, the mice were perfused with 4% PFA; tissues were harvested and processed for 
iDISCO protocol as described above. 
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